These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 33199022)

  • 1. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Groves DC; Rowland-Jones SL; Angyal A
    Biochem Biophys Res Commun; 2021 Jan; 538():104-107. PubMed ID: 33199022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The virological impacts of SARS-CoV-2 D614G mutation.
    Wang C; Zheng Y; Niu Z; Jiang X; Sun Q
    J Mol Cell Biol; 2021 Dec; 13(10):712-720. PubMed ID: 34289053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike mutation D614G alters SARS-CoV-2 fitness.
    Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
    Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Volz E; Hill V; McCrone JT; Price A; Jorgensen D; O'Toole Á; Southgate J; Johnson R; Jackson B; Nascimento FF; Rey SM; Nicholls SM; Colquhoun RM; da Silva Filipe A; Shepherd J; Pascall DJ; Shah R; Jesudason N; Li K; Jarrett R; Pacchiarini N; Bull M; Geidelberg L; Siveroni I; ; Goodfellow I; Loman NJ; Pybus OG; Robertson DL; Thomson EC; Rambaut A; Connor TR
    Cell; 2021 Jan; 184(1):64-75.e11. PubMed ID: 33275900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Jackson CB; Zhang L; Farzan M; Choe H
    Biochem Biophys Res Commun; 2021 Jan; 538():108-115. PubMed ID: 33220921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
    Li X; Zhang L; Chen S; Ji W; Li C; Ren L
    Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
    Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
    Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 evolution and vaccines: cause for concern?
    Williams TC; Burgers WA
    Lancet Respir Med; 2021 Apr; 9(4):333-335. PubMed ID: 33524316
    [No Abstract]   [Full Text] [Related]  

  • 11. Making sense of spike D614G in SARS-CoV-2 transmission.
    Shi AC; Xie X
    Sci China Life Sci; 2021 Jul; 64(7):1062-1067. PubMed ID: 33587268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving threat.
    Kupferschmidt K
    Science; 2021 Aug; 373(6557):844-849. PubMed ID: 34413220
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.
    Volkan E
    Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
    Weissman D; Alameh MG; de Silva T; Collini P; Hornsby H; Brown R; LaBranche CC; Edwards RJ; Sutherland L; Santra S; Mansouri K; Gobeil S; McDanal C; Pardi N; Hengartner N; Lin PJC; Tam Y; Shaw PA; Lewis MG; Boesler C; Şahin U; Acharya P; Haynes BF; Korber B; Montefiori DC
    Cell Host Microbe; 2021 Jan; 29(1):23-31.e4. PubMed ID: 33306985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
    Tcheou J; Raskin A; Singh G; Kawabata H; Bielak D; Sun W; González-Domínguez I; Sather DN; García-Sastre A; Palese P; Krammer F; Carreño JM
    Front Immunol; 2021; 12():791764. PubMed ID: 34868082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.